Materials & Resources » Chemicals | Jubilant Life Sciences Ltd.

Jubilant Life Sciences Ltd. | Income Statement

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Sales/Revenue
57,216
57,761
56,918
57,956
75,178
Cost of Goods Sold (COGS) incl. D&A
45,919
48,372
43,738
42,665
50,876
Gross Income
11,297
9,389
13,180
15,292
24,303
SG&A Expense
4,273
5,254
3,933
4,632
12,359
EBIT
6,597
3,646
-
10,739
11,944
Unusual Expense
2,288
159
-
-
910
Non Operating Income/Expense
1,082
212
58
39
400
Interest Expense
3,371
3,676
3,714
3,411
2,843
Pretax Income
2,073
403
5,422
7,376
8,591
Income Tax
696
805
1,554
1,630
2,247
Consolidated Net Income
1,376
402
3,868
5,746
6,344
Net Income
1,090
578
3,918
5,757
6,428
Net Income After Extraordinaries
1,090
578
3,918
5,757
6,428
Net Income Available to Common
1,090
578
3,918
5,757
6,428
EPS (Basic)
6.85
3.63
25.10
36.93
41.25
Basic Shares Outstanding
159
159
156
156
-
EPS (Diluted)
6.85
3.63
25.08
36.91
-
Diluted Shares Outstanding
159
159
156
156
-
EBITDA
9,409
6,525
12,634
13,653
15,184
Other Operating Expense
427
489
80
80
-
Non-Operating Interest Income
52
62
27
88
-
Minority Interest Expense
286
176
50
10
84

About Jubilant Life Sciences

View Profile
Address
1A, Sector-16A
Noida Uttar Pradesh 201301
India
Employees -
Website http://www.jubl.com
Updated 09/14/2018
Jubilant Life Sciences Ltd. is a global pharmaceutical and life sciences company specializing in ingredients, generics, and drug discovery and development. It operates through the Pharmaceuticals and Life Science Ingredients. The Pharmaceuticals segment refers to Indian Branded Pharmaceuticals.